YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[Business graph, chart green background.Copy space] design master * Gingko Bioworks (DNA [https://seekingalpha.com/symbol/DNA]) closed Monday up ~21% as options trading surged. * The stock has been on a tear of late. Over the last month, s…
[mrna Cancer Vaccine] wildpixel/iStock via Getty Images INVESTORS SHOULD KNOW: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma into a broader test across harder-to-treat solid tumors. The…
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $12.50, moving -2.57% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.2%. Elsewhere, the Dow saw an upswing of 0.0…
Ginkgo generates antibody data at scale and trains models for drug manufacturability and developability. Apheris' federated infrastructure enables participating pharmaceutical companies to use those models and further fine-tune them on the…
[Ozempic Insulin injection pen] CR/iStock via Getty Images INVESTORS SHOULD KNOW: The obesity drug market is undergoing a structural shift, moving beyond the initial injectable GLP-1 franchise. Now, the industry is moving toward a broader…
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.58, marking a -8.43% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.76%. At the same time, the Dow lost 0.68%, a…
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $7.06 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily loss of 0.45%. Elsewhere, the Dow lost 1.21%, while the tech-heavy Nasdaq los…
[Two coloured ropes knotted together] Richard Drury Twist Bioscience (TWST [https://seekingalpha.com/symbol/TWST]) and Ginkgo Bioworks (DNA [https://seekingalpha.com/symbol/DNA]) traded higher on Wednesday after announcing agreements with…
Integration puts Ginkgo's biological data generation services at the heart of the industry's most prominent AI-driven drug discovery network BOSTON, September 16, 2026--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced that its…
NORTHAMPTON, MA / ACCESS Newswire / September 9, 2026 / Organizations Across Sectors Unite Through the Winn Awards to Advance Better Science For All Previously published by the Robert A. Winn Excellence in Clinical Trials Award Program A g…
[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [http…
Quick Read Tempus AI (TEM) hit five straight EPS beats with shares up 17%, as Twist Bioscience (TWST) logged 14 straight quarters of sequential revenue growth. Anthropic targets a September IPO with a healthcare AI pitch that could front-r…
Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035" h…
Key Points Interested in Ginkgo Bioworks Holdings, Inc.? Here are five stocks we like better. Revenue fell sharply: Second-quarter 2026 revenue declined 48% year over year to $20 million, while net loss widened to $57 million and cash burn…
Ginkgo Bioworks Holdings, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Shift Toward Autonomous Laboratory Infrastructure Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll…
Palantir (NASDAQ: PLTR) and Ginkgo Bioworks(NYSE: DNA) sit on opposite sides of a fast-emerging biosecurity debate. Palantir represents the intelligence layer, while Ginkgo represents the biological infrastructure layer. The question is wh…
Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Oncology Clinical Trials Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oncology clinical trials market has seen substantial growth, transitioning from $14.99 bi…
Ginkgo Bioworks logo Key Points Autonomous labs become Ginkgo’s core 2026 strategy: the company will concentrate capital there, systematically move work from traditional benches onto its Nebula system in Boston, expand rack capacity toward…
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.00 in the latest trading session, marking a -3.12% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.1%. On the other hand, the Dow registered a gain o…
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $9.23, moving -9.06% from the previous trading session. This move lagged the S&P 500's daily loss of 0.33%. At the same time, the Dow added 0.1%, and the tech-heavy…
This article first appeared on GuruFocus. Ginkgo Bioworks (NYSE:DNA) says a new AI collaboration with OpenAI is already paying off, cutting the cost of protein production in the lab by a meaningful margin. The company said it worked with O…
[Collaboration concept in word tag cloud] rafal_olechowski Ginkgo Bioworks Holdings (DNA [https://seekingalpha.com/symbol/DNA]) announced on Thursday that, in collaboration with Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT])-backe…
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.31 in the latest trading session, marking a -1.27% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.13%. Elsewhere, the Dow gained 0.11%, while the…
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.02 in the latest trading session, marking a -6.36% move from the prior day. This change lagged the S&P 500's 0.03% gain on the day. Elsewhere, the Dow saw a downswing of 0.58%, while the t…
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.85 in the latest trading session, marking a +2.39% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.53%. At the same time, the Dow lost 0.09%, and the…
BOSTON, Jan. 13, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026 at 10:30 a.m.…
In the latest close session, Ginkgo Bioworks Holdings, Inc. (DNA) was up +1.96% at $8.31. The stock's change was more than the S&P 500's daily loss of 0.74%. On the other hand, the Dow registered a loss of 0.63%, and the technology-centric…
The Winn Awards community welcomes 79 new physician-researchers from 23 states NORTHAMPTON, MA / ACCESS Newswire / November 12, 2025 / Originally published by The Robert A. Winn Excellence in Clinical Trials Award Program The Robert A. Win…
(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) on Thursday reported third-quarter net loss of $80.76 million or $1.45 per share, compared to $56.40 million or $1.08 per share in the comparable prior year period. Third-quarter total reven…
* Ginkgo Bioworks Holdings (DNA [https://seekingalpha.com/symbol/DNA]) is scheduled to announce Q3 earnings results on Thursday, November 6th, after market close. * The consensus EPS Estimate is -$1.24 [https://seekingalpha.com/symbol/DNA/…
Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure BOSTON, Nov. 3, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that it has been award…
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to advance research and development of biological products for agriculture. Wit…
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.74, marking a -4.85% move from the previous day. This change lagged the S&P 500's daily gain of 0.23%. Meanwhile, the Dow experienced a rise of 0.34%, and th…
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.78 in the latest trading session, marking a -2.67% move from the prior day. This change lagged the S&P 500's daily loss of 0.53%. Elsewhere, the Dow saw a downswing of 0.71%, while the tec…
Ginkgo Bioworks Holdings, Inc. (DNA) ended the recent trading session at $15.12, demonstrating a -4.49% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss of 0.63%. Meanwhile, the Do…
In the latest close session, Ginkgo Bioworks Holdings, Inc. (DNA) was up +1.06% at $16.14. The stock's change was more than the S&P 500's daily gain of 0.01%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centri…